Navigation Links
Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS
Date:9/20/2008

e and Specialty Medicine, which includes Hematology, Oncology and Multiple Sclerosis. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

(1) MS Freedman, L Kappos, CH Polman, et al. Impact of Early Interferon beta-1b Treatment on Disease Evolution Over 5 Years in Patients with a First Event Suggestive of Multiple Sclerosis. World Congress on Treatment and Research in Multiple Sclerosis 2008.

(2) Kappos L et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007 Aug 4; 370(9585): 389-97


'/>"/>
SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
2. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
3. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
4. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
5. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate
6. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...,China,Nov.25/PRNewswire-Asia-FirstCall/--ChinaSky...")(Nasdaq: CSKI ),a,leadingfullyintegratedpharmace...erdrugsinthePeople,sRepublicofChina("PRC"),today,a...onalInstitutefor,theControlofPharmaceuticalandBiol...roducts:itsDiagnosticKitforHumanProstateSpecific,A...
(Date:11/25/2009)...M,Mass.,Nov.25/PRNewswire/--AccordingtoMillenniumR...ologymarketintelligence,thenearly$3billionUSmarket...thoverthenextfiveyearsdespitetherecenteconomicslow...indsthatthismarketwillremainhighlydynamicoverthene...evicesinpreviouslyunderservedsegmentsofthetraumafi...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 1Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 2Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 3Mayo Clinic 26apos 3Bs Dr Denis Cortese Receives NCHL 26apos 3BS 2009 National Healthcare Leadership Award 51863 4Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 1Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 2Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 3Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease 4730 4Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 1Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 2Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 3Frost 26 Sullivan 3A North American Government Biometrics Markets Thrive With Active R 26D Thrust 9273 4
...new tool that works within minutes, upon European ...TH, N.J., June 2 Schering-Plough,Corporation (NYS...dicinal,Products for Human Use (CHMP) of the Europ...al of sugammadex for routine reversal of the muscl...iate reversal of rocuronium,in adults, and for rou...
... results of the Spare the,Nephron (STN) study, a m...ing treatment protocol using CellCept(R) (mycophen...in combination with sirolimus,(SRL) is associated ...e,CellCept-based regimen in combination with calci...showed this improvement without increasing the,ris...
Other Medicine Technology:European Union's CHMP Issues Positive Opinion on Sugammadex 2European Union's CHMP Issues Positive Opinion on Sugammadex 3European Union's CHMP Issues Positive Opinion on Sugammadex 4European Union's CHMP Issues Positive Opinion on Sugammadex 5Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 2Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 3Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 4Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function 5
(Date:11/25/2009)...ht rheumatoid arthritis, could help newly diagnose...Nov. 25 (HealthDay News) -- A drug commonly used t...ritis now also shows some promise in helping patie... drug, rituximab (Rituxan), helped patients keep p...e disease had destroyed some of their pancreatic b...
(Date:11/25/2009)...ead mothers to overlook needed care, study finds ,...- A mother,s depression can worsen her child,s ast...onth study of 262 black mothers and their children...sive symptoms had more frequent asthma symptoms, w...ptoms had less frequent asthma symptoms. , The ...
(Date:11/25/2009)...s few signs of trouble with the H1N1 vaccine, , ...The ongoing H1N1 swine flu pandemic may be driving...ger patients, a U.S. health official said Wednesda...mococcal infections around the country," Dr. Anne ...nization and Respiratory Diseases at the U.S. Cent...
(Date:11/25/2009)...RNewswire-USNewswire/--TheAmericanAssociationforHo...09,"S.2128,whichisdesignedtosubstantiallyimproveto...hebillwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,...icanAssociationforHomecareoutlinedinits13-pointant...gressinFebruary.Thoseprovisionsincludecallingforre...
(Date:11/25/2009)... vaccine carried into the body on a carefully engi...uccessfully eliminate tumors in mammals, scientist...tional Medicine . , The new approach, pioneered ...rsity, uses plastic disks impregnated with tumor-s...eprogram the mammalian immune system to attack tum...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2
...le called RBP4 (retinol binding protein 4) is an i...f insulin resistance //, the main cause of type 2...bolic syndrome, according to a recent study. ...tifying individuals who are at risk of developing ...
... to develop human disease research, now proved 95 ... of extremely //complex virus - the vaccinia virus...archers at the La Jolla Institute for Allergy & Im...e to one of the most complex viruses known to man ...
... spells heaven for millions of avian influenza pat...e Children’s Research Hospital //. According to th...s potent against one antigenic variant of the avia...rus. The great thing about such vaccines is t...
...mpaign for removal of Union Health Minister Anbuma... today sought// removal of AIIMS Director P Venugo...hind the agitation by medical students in Delhi ag...nti-quota protests against 27 per reservation for ...
... of HIV positive patients in Bihar, a high profile...e legislature and those connected// with AIDS awar...d means for a more forceful drive against the drea...rces said. Top officials of National AIDS Co...
...senior BJP leader Sushma Swaraj today expressed co...ter A Ramadoss and AIIMS Director P Venugopal// , ... "I am very sad at what is happening concerni...ng there and it is churning out the best brains in...
Other Medicine News:Health News:A New Marker For Type-2 Diabetes ? 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 2Health News:Bioinformatics Made a Boon In Immune Response Study - LIAI Finds 3Health News:Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants 2
...pinal Implant system. Material that has a modulus ... The result is an implant that meets the structura...ptimizing the fusion environment through an open, ...gn with 5 and 10 degrees of lordosis. Minimal inst...
...em provides anterior column support for single or ...rom T1 to L5. The system consists of one or more P... a desired height, accommodating various patient n...erial emulates the biomechanical properties of hum...
Rotafix Intervertebral Cage
Miniflex
Medicine Products: